Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Polaris Venture Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Polaris Venture Capital is committed to building successful enterprises through value-added partnerships with promising technology companies. With the recent closing of Polaris Fund III, and the merger of the management team of Polaris with the Eucalyptus Ventures management team, Polaris Venture Capital is by far the largest and most experienced venture capital management group originating in Israel. Possessing vast experience in equity investments and high-technology management, Polaris Venture Capital is now managing over $700 million.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2006 | Allurent | Series A | - |
| 6/2005 | ClearView Audio | Series A | 7M |
| 9/2018 | Lyra Therapeutics | Series B | 0 |
| 10/2000 | Ingenium Pharmaceuticals AG | Series B | 44M |
| 8/2008 | ClearView Audio | Venture Round | 4M |
| 5/2007 | ClearView Audio | Venture Round | 3M |
| 5/2008 | Selecta Biosciences | Seed Round | 2.5M |
| 2/2001 | Phonetic Systems | Private Equity Round | 0 |
| 12/2017 | Respicardia | Venture Round | 0 |
| 7/2009 | Avila Therapeutics | Series B | 30M |
| 3/2013 | Avitide | Series A | 1.4M |
| 3/2015 | aTyr Pharma | Series E | 76M |
| 8/2000 | SercoNet | Series B | 5M |
| 2/2021 | Seraxis | Series C | 40M |
| 2/2006 | Imprivata | Series B | 12M |
| 6/2013 | Ocular Therapeutix | Series D | 23.8M |
| 3/2019 | NakedPoppy | Seed Round | 4.1M |
| 11/1999 | Vigil Technologies, Inc. | Series B | 5.5M |
| 5/2017 | Cardlytics | Series G | 0 |
| 2/2021 | Seraxis | Series C | 0 |
| 3/2019 | NakedPoppy | Seed Round | 0 |
| 9/2018 | Lyra Therapeutics | Series B | 0 |
| 12/2017 | Respicardia | Venture Round | 0 |
| 5/2017 | Cardlytics | Series G | 0 |
| 3/2015 | aTyr Pharma | Series E | 0 |
| 6/2013 | Ocular Therapeutix | Series D | 0 |
| 3/2013 | Avitide | Series A | 0 |
| 7/2009 | Avila Therapeutics | Series B | 0 |
| 8/2008 | ClearView Audio | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
